top of page
首页.png

A Better Now
For A Better Future

Science-based neuromodulation dedicated to sleep improvement and major brain disease prevention

Global patented technology

Non-invasive physical approach

Supported by 20 years research 

We’re Proud to Join the Alzheimer's Moonshot

AD_Moonshot-removebg-preview.png

NeuDreamer is now part of the Alzheimer's Moonshot, a groundbreaking initiative led by StartUp Health in partnership with Gates Ventures and the Alzheimer’s Drug Discovery Foundation (ADDF).

Quality Sleep: A Foundation for the Future

Sleep plays a crucial role in the onset and progression of major brain diseases, serving as an early indicator and modifiable target.

Why choose NeuDreamer

Reclaim Your Right to Quality Sleep

Experience the profound impact of better sleep as we empower you to achieve it naturally, without dependency on external aids, eventually.

Designed for Non-Hospital Usage

We are committed to developing a low-intensity, safe, and side-effect-free approach. The application in non-hospital settings caters to a variety of needs, including preventing the relapse of depression.

Proven Safety and Effectiveness

Years of market feedback have validated the integration of our technology into mature product designs for both safety and effectiveness.

Driving AD Preparedness

Anticipating the challenge of an aging society, we aim to drive comprehensive clinical research to envision a future where Alzheimer's Disease no longer poses concerns.

YEAR

2005

The Start of rDMS

Focused on the application and mechanism research of Deep Brain Magnetic Stimulation (rDMS) technology in the fields of brain health and brain diseases

YEAR

2014

Promote Adult Hippocampal Neurogenesis

We found evidence demonstrating that rDMS enhances the proliferation of adult neural progenitor cells in DG,

Milestones

We Correspond to 7 Targets in the Current AD Drug Development Pipeline

The Research Behind

bottom of page